Cite
HARVARD Citation
Carlo-Stella, C. et al. (2015). Brentuximab Vedotin in Patients With Hodgkin Lymphoma and a Failed Allogeneic Stem Cell Transplantation: Results From a Named Patient Program at Four Italian Centers. Oncologist. pp. 323-328. [Online].